Magda Szubanski reveals cancer diagnosis

By
Megan Cartwright is Newsweek's Deputy Entertainment Editor, based in London, U.K. Her focus is on U.S. pop culture and entertainment news stories. Megan joined Newsweek in 2022 from New York where she was the Senior Editor for In Touch, Life & Style and Closer magazines and had previously interned at MTV, Cosmopolitan and InStyle. She is a graduate of Fairleigh Dickinson University. Languages: English.
You can get in touch with Megan by emailing m.cartwright@newsweek.com.
Megan Cartwright and
Shane Croucher is a Breaking News Editor based in London, UK. He has previously overseen the My Turn, Fact Check and News teams, and was a Senior Reporter before that, mostly covering U.S. news and politics. Shane joined Newsweek in February 2018 from IBT UK where he held various editorial roles covering different beats, including general news, politics, economics, business, and property. He is a graduate of the University of Lincoln, England. Languages: English. You can reach Shane by emailing s.croucher@newsweek.com
Deputy Entertainment Editor
news article
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Share
✓ Link copied to clipboard!
Listen
Translate
- English (Original)
- Español
- 中国人
- Français
- Deutsch
- Portuguese
- हिन्दी
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Read original
Speed: 0.5xSpeed: 1xSpeed: 1.5xSpeed: 2x
🎙️ Voice is AI-generated. Inconsistencies may occur.
✖
Australian actress and comedian Magda Szubanski revealed she has been diagnosed with a rare and aggressive form of cancer.
Szubanski, 64, said in a post on Instagram that she has stage 4 mantle cell lymphoma.
"It is one of the nasty ones, unfortunately," Szubanski said in a video accompanying the post.
"But the good thing is I'm surrounded by beautiful friends and family, and an incredible medical support team."
This is a developing article and more information will be added soon.

